A profile of inpatient STD-related pelvic inflammatory disease in the Top End of the Northern Territory of Australia

Medical Journal of Australia

Volumn 166, Issue 9, 1997, Pages 464-467

  Mein, Jacki ^a   Bowden, Francis J ^a,b  

^a Territory Health Services   (Australia)

^b AIDS/STD Unit   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PENICILLIN G;

ABORIGINE; ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; CHLAMYDIACEAE; CLINICAL FEATURE; DISEASE DURATION; FEMALE; GONORRHEA; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; PELVIC INFLAMMATORY DISEASE; SEXUALLY TRANSMITTED DISEASE; VAGINA SMEAR;

EID: 0030915312     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1997.tb123217.x     Document Type: Article

References (21)

1. Bowden F. Surveillance of sexually transmitted diseases in the Northern Territory of Australia. Venereology 1995; 8: 21-25.
2. Soper DE. Diagnosis and laparoscopic grading of acute salpingitis. Am J Obstet Gynaecol 1991; 164: 1370-1376.
3. Epi Info version 6 [computer program]. Atlanta: Centers for Disease Control and Prevention, 1994.
4. Aral SO, Mosher WD, Gates W. Self-reported pelvic inflammatory disease in the United States, 1988. JAMA 1991; 266: 2565-2569.
5. McNeeley SG. Pelvic inflammatory disease. Curr Opin Obstet Gynaecol 1992; 4: 682-686.
6. Rolfs RT, Galaid EI, Zaidi AA. Pelvic inflammatory disease: trends in hospitalisations and office visits, 1979 through 1988. Am J Obstet Gynecol 1992; 166: 983-990.
7. Westrom L, Mardh P-A. Acute pelvic inflammatory disease. In: Holmes KK, Mardh PA, Sparling PF, editors. Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill, 1990: 593-614.
8. Grodstein F, Rothman KJ. Epidemiology of pelvic inflammatory disease. Epidemiology 1994; 5: 234-242.
9. Russell ML, Love EJ. Pelvic inflammatory disease: cumulative incidence in primary care. Clin Invest Med 1992; 15: 66-70.
10. Washington E, Aral SO. Assessing risk for pelvic inflammatory disease and its sequelae. JAMA 1991; 266: 2581-2586.
11. Westrom L. The effect of pelvic inflammatory disease on fertility. Venereology 1995; 8: 220-223.
12. McCormack WM. Pelvic inflammatory disease. N Engl J Med 1994; 330: 115-119.
13. Kahn JG, Walker CK, Washington E, et al. Diagnosing pelvic inflammatory disease. A comprehensive analysis and considerations for developing a new model. JAMA 1991; 266: 2594-2604.
14. Washington E, Gates W, Wasserheit JN. Preventing pelvic inflammatory disease. JAMA 1991; 266: 2570-2573.
15. Wein P, Kloss M, Garland S. Postabortal pelvic sepsis in association with Chlamydia trachomatis. Aust N Z J Obstet Gynaecol 1990; 30: 347-350.
16. Westrom L, Wohlner-Hanssen P. Pathogenesis of pelvic inflammatory disease. Genitourin Med 1993; 69: 9-17.
17. Therapeutics committee, Victorian Postgraduate Medical Foundation. Antibiotic guidelines. 8th ed. Melbourne: Interprint Services, 1994.
18. Pastorek JG. Antibiotic therapy for pelvic inflammatory disease. J Reprod Med 1990; 35 Suppl 3: 329-332.
19. Peterson HB, Walker CK, Kahn JG, et al. Pelvic inflammatory disease. Key treatment issues and options. JAMA 1991; 266: 1370-1376.
20. Corrado ML. The clinical experience with ofloxacin in the treatment of sexually transmitted diseases. Am J Obstet Gynaecol 1991; 164: 1396-1399.
21. Wendel GD, Cox SM, Bawdon RE, et al. A randomised trial of ofloxacin versus cefoxitin in the outpatient treatment of acute salpingitis. Am J Obstet Gynecol 1991; 164: 1390-1395.